Biofil Chemicals (BIOFILCHEM) | Stock Overview & Key Data
Biofil Chemicals Performance Comparison
Stock Range
Today's Range
Low: ₹42.60
High: ₹43.69
on August 19, 2025
52 Week Range
Low: ₹40.40
High: ₹91.87
on March 17, 2025
on September 16, 2024
All-Time High: ₹356.10 on December 14, 2020
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR710.8M
EPS
0.34
P/E Ratio (TTM)
128.47
Forward P/E
N/A
P/B Ratio
3.87
PEG Ratio
N/A
Div. Yield
N/A
ROE
3.02%
Beta
0.968
Debt to Equity
2.51
Financial Highlights
Profitability
Gross Margin
6.55%
Operating Margin
3.13%
Profit Margin
1.67%
Returns and Earnings
Return on Assets (TTM)
0.99%
Return on Equity (TTM)
3.02%
EBITDA
INR11.5M
Net Income (TTM)
INR5.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR20.53
Quarterly Revenue Growth (YoY)
-46.40%
Quarterly Earnings Growth (YoY)
-19.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Biofil Chemicals BIOFILCHEM | 710.84M Small-cap | -1.52% | -6.66% | -8.13% | -10.89% | -29.49% | -37.25% | -18.95% | 18.91% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 1.51% | -3.60% | -5.64% | -4.05% | -13.61% | -8.06% | 85.50% | 193.78% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | 2.88% | -8.42% | -6.31% | 5.56% | 1.51% | 26.95% | 71.83% | 88.35% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | 0.77% | -10.89% | -14.09% | 10.37% | -28.50% | -35.54% | -38.19% | -24.48% |
| Aarti Drugs AARTIDRUGS | 44.42B Small-cap | 2.95% | -3.70% | 4.84% | 32.38% | 10.61% | -10.65% | 15.02% | -31.24% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | -0.83% | -6.65% | -1.09% | 18.65% | -5.03% | 5.29% | 52.33% | 30.44% |
Ownership & Short Interest
Insider Ownership
61.58%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
8K
Average 90-Day Volume
7K
Biofil Chemicals Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Biofil Chemicals would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BIOFILCHEM's 52-week high and low?
- In the last 52 weeks, Biofil Chemicals reached a high of ₹91.87 (on September 16, 2024) and a low of ₹40.40 (on March 17, 2025).
- What is the market cap and P/E ratio for BIOFILCHEM?
- Curious about Biofil Chemicals's size and valuation? Its market capitalization stands at 710.84M. When it comes to valuation, the P/E ratio (trailing twelve months) is 128.47, and the forward P/E (looking ahead) is N/A.
- Does BIOFILCHEM pay dividends? If so, what's the yield?
- As for dividends, Biofil Chemicals isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Biofil Chemicals's main competitors or similar companies to consider before investing?
When looking at Biofil Chemicals, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.06% 85.50% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.95% 71.83% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -35.54% -38.19% Aarti Drugs
AARTIDRUGS44.42B Healthcare Drug Manufacturers - Specialty & Generic -10.65% 15.02% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 5.29% 52.33% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Biofil Chemicals & Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Biofil Chemicals's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.02%, the Debt to Equity ratio from the most recent quarter is 2.51, and its Gross Profit Margin stands at 6.55%.
- What is the recent revenue and earnings growth for BIOFILCHEM?
- Looking at Biofil Chemicals's growth, its revenue over the trailing twelve months (TTM) was INR334M. Compared to the same quarter last year (YoY), quarterly revenue grew by -46.40%, and quarterly earnings saw a YoY growth of -19.80%.
- How much of BIOFILCHEM stock is held by insiders and institutions?
- Wondering who owns Biofil Chemicals stock? Company insiders (like executives and directors) hold about 61.58% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.